Mao ND - Search Results

1

Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents.

Yuan YH, Mao ND, Duan JL, Zhang H, Garrido C, Lirussi F, Gao Y, Xie T, Ye XY. Yuan YH, et al. Among authors: mao nd. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2279906. doi: 10.1080/14756366.2023.2279906. Epub 2023 Nov 13. J Enzyme Inhib Med Chem. 2023. PMID: 37955299 Free PMC article. Review.

2

Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR).

Wang LW, Jiang S, Yuan YH, Duan J, Mao ND, Hui Z, Bai R, Xie T, Ye XY. Wang LW, et al. Among authors: mao nd. Molecules. 2022 Apr 12;27(8):2491. doi: 10.3390/molecules27082491. Molecules. 2022. PMID: 35458687 Free PMC article. Review.

3

Recent Progress in Fragmentation of Katritzky Salts Enabling Formation of C-C, C-B, and C-S Bonds.

Gao Y, Jiang S, Mao ND, Xiang H, Duan JL, Ye XY, Wang LW, Ye Y, Xie T. Gao Y, et al. Among authors: mao nd. Top Curr Chem (Cham). 2022 May 19;380(4):25. doi: 10.1007/s41061-022-00381-x. Top Curr Chem (Cham). 2022. PMID: 35585362 Review.

4

Novel hydroxyl carboximates derived from β-elemene: design, synthesis and anti-tumour activities evaluation.

Gao Y, Mao ND, Che H, Xu L, Bai R, Wang LW, Ye XY, Xie T. Gao Y, et al. Among authors: mao nd. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2403-2416. doi: 10.1080/14756366.2022.2117314. J Enzyme Inhib Med Chem. 2022. PMID: 36065895 Free PMC article.

5

Recent progress in nickel-catalyzed carboboration of alkenes.

Ye Y, Lin Y, Mao ND, Yang H, Ye XY, Xie T. Ye Y, et al. Among authors: mao nd. Org Biomol Chem. 2022 Dec 7;20(47):9255-9271. doi: 10.1039/d2ob01855a. Org Biomol Chem. 2022. PMID: 36399007 Review.

6

Design, Synthesis and Biological Evaluation of Histone Deacetylase Inhibitors Based on Pyrrolo[2,3-d]pyrimidine and Pyrrolo[2,3-b]pyridine Scaffolds.

Mao ND, Gao Y, Dang XW, Duan JL, Hui Z, Che H, Xu Y, Zhang H, He X, Garrido C, Ye XY. Mao ND, et al. ChemMedChem. 2023 Jul 17;18(14):e202200683. doi: 10.1002/cmdc.202200683. Epub 2023 Jun 26. ChemMedChem. 2023. PMID: 37126396

7

Design, synthesis and biological evaluation of novel 1,2,4a,5-tetrahydro-4H-benzo[b][1,4]oxazino[4,3-d][1,4]oxazine-based AAK1 inhibitors with anti-viral property against SARS-CoV-2.

Mao ND, Xu Y, Che H, Yao X, Gao Y, Wang C, Deng H, Hui Z, Zhang H, Ye XY. Mao ND, et al. Eur J Med Chem. 2024 Mar 15;268:116232. doi: 10.1016/j.ejmech.2024.116232. Epub 2024 Feb 12. Eur J Med Chem. 2024. PMID: 38377825

8

Design, Synthesis, and Structure-Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition.

Duan JL, Wang CC, Yuan Y, Hui Z, Zhang H, Mao ND, Zhang P, Sun B, Lin J, Zhang Z, Gao Y, Xie T, Ye XY. Duan JL, et al. Among authors: mao nd. J Med Chem. 2024 Mar 28;67(6):4950-4976. doi: 10.1021/acs.jmedchem.4c00090. Epub 2024 Mar 8. J Med Chem. 2024. PMID: 38456618

9

Recent advances of small-molecule c-Src inhibitors for potential therapeutic utilities.

Dang XW, Duan JL, Ye E, Mao ND, Bai R, Zhou X, Ye XY. Dang XW, et al. Among authors: mao nd. Bioorg Chem. 2023 Oct 23;142:106934. doi: 10.1016/j.bioorg.2023.106934. Online ahead of print. Bioorg Chem. 2023. PMID: 39492169 Review.

10

Design, synthesis, and biological evaluation of novel AAK1/HDACs dual inhibitors against SARS-CoV-2 entry.

Mao ND, Xu Y, Yao X, Gao Y, Hui Z, Che H, Wang C, Lu J, Yu J, Hu S, Zhang H, Ye XY. Mao ND, et al. Bioorg Chem. 2024 Dec;153:107973. doi: 10.1016/j.bioorg.2024.107973. Epub 2024 Nov 19. Bioorg Chem. 2024. PMID: 39581172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters